Headache Disorders: Clinical Trials

2,137 trials for Headache Disorders, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1252 completed, 292 unknown, 202 recruiting, 130 terminated. 890 Not applicable, 289 Phase 3, 234 Phase 2, 200 Phase 4, 130 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable890Completed 486, Unknown 133, Recruiting 93, Not yet recruiting 57, Terminated 51, Active not recruiting 29, Withdrawn 26, Enrolling by invitation 11, Suspended 4
Phase 3289Completed 209, Recruiting 20, Terminated 17, Unknown 17, Withdrawn 15, Not yet recruiting 4, Active not recruiting 3, Enrolling by invitation 3, Suspended 1
Phase 2234Completed 147, Terminated 29, Unknown 21, Recruiting 18, Withdrawn 8, Not yet recruiting 6, Active not recruiting 2, Enrolling by invitation 2, Suspended 1
Phase 4200Completed 124, Unknown 25, Terminated 18, Recruiting 12, Not yet recruiting 9, Withdrawn 6, Active not recruiting 4, Enrolling by invitation 1, Suspended 1
Phase 1130Completed 99, Terminated 10, Unknown 10, Withdrawn 4, Not yet recruiting 3, Enrolling by invitation 2, Recruiting 2
Early Phase 112Completed 6, Recruiting 3, Unknown 2, Terminated 1

Follow Headache Disorders: new trials by email Literature Review of Headache Disorders trials Research Report on Headache Disorders

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Observational Study to Assess Migraine Prediction Tool
Daily questionnaire - Migraine
SuspendedTheranica2002030-01-012024-11-22
EMBRACE Study: Enduring Migraine Benefit From Responsive Artery Coil Embolization
TEMMA Endovascular Treatment - Migraine Disorders, Refractory Migraine
Not applicableWithdrawnCortex Neurovascular2028-03-012026-10-27
Behavior Therapy vs Education for Persistent Headache After Mild TBI
Headache reprocessing, Headache education - Post-Traumatic Headache
Not applicableNot yet recruitingVA Office of Research and Development602027-10-012025-12-26
Calcitonin Gene-related Peptide Antibody in Acute Mountain Sickness
Fremanezumab 225 Mg/1.5 mL Subcutaneous Solution, Placebo - Acute Mountain Sickness
Phase 4Not yet recruitingInsel Gruppe AG, University Hospital Bern302027-06-012026-07-01
Nortriptyline Compared With Amitriptyline for Migraine Prevention at SQUH
Nortriptyline, Amitriptyline - Migraine
Phase 4Not yet recruitingSultan Qaboos University902027-05-012026-10-02
A Basket Clinical Study to Assess Glycerol Tributyrate in Patients With Mitochondrial Encephalopathy, Lactic Acidosis, Stroke-like Episodes (MELAS) or Leber's Hereditary Optic Neuropathy-Plus (LHON-Plus)
Glycerol Tributyrate - MELAS Syndrome, Lebers Hereditory Optic Neuropathy With Extra Ocular Symptoms (LHON-Plus)
Phase 1 / Phase 2Not yet recruitingGeorge Washington University242027-03-012026-10-05
Migraine Menopause Study
Eptinezumab 100 mg or Eptinezumab 300 mg administered intravenously in 100 mL saline solution, Placebo Normal Saline (NS) - Migraine, Menopausal
Phase 4Not yet recruitingAlberta Neurologic Centre1202027-02-012026-11-04
Multimodal Therapy for Somatosensory Tinnitus
Multimodal physiotherapy for TMJ and Cervical spine, Combined Exercise Program (Aerobic + Resistance + Breathing), Tinnitus-Specific Psychological Support - Ear Noise, Tinnitus, Noise Induced
Not applicableNot yet recruitingCharles University, Czech Republic1602027-01-012026-03-12
Effect of Atogepant on the Vestibulo-Ocular Reflex in Healthy Adults and Adults With Migraine
Atogepant 60 mg, Placebo - Migraine Disorders, Brain, Healthy Adult Participants
Phase 4Not yet recruitingKonrad Peter Weber802027-01-012026-09-17
Visual Instillation of Sphenopalatine-block Intervention for ONgoing Migraine
Topical solution of 4% lidocaine, Saline 0.9% - Migraine, Facial Pain or Pressure
Phase 2Not yet recruitingAssociation of Migraine Disorders742027-01-012026-11-09
A Pivotal Clinical Study to Evaluate the MySalvia System for the Treatment of Resistant Migraine
Neurostimulator - Resistant Migraine, Chronic Migraine Headache
Not applicableRecruitingSalvia BioElectronics1502026-12-012026-08-28
Efficacy, Safety and Tolerability of Low Sodium Oxybate for Nocturnal Cluster Headache Attacks
Low Sodium Oxybate, Placebo - Chronic Cluster Headache
Phase 2Not yet recruitingLeiden University Medical Center522026-12-012026-08-25
Sequential, Multiple Assignment, Double Randomized Preference, Migraine Behavioral Trial
Migraine Behavioral Treatment - Migraine, Headache
Not applicableNot yet recruitingMayo Clinic242026-12-012026-06-16
Comparing Spinal, Epidural, and Dural Puncture Epidural Anesthesia for Cesarean Delivery: Hemodynamics and Block Quality
Spinal Anesthesia, Epidural Anesthesia, Dural Puncture Epidural Anesthesia - Hypotension After Neuraxial Anesthesia, Cesarean Section
Not applicableNot yet recruitingBursa Yuksek Ihtisas Training and Research Hospital1202026-12-012026-10-20
A Prospective Study of Rimegepant for Short-term Preventive Treatment of Night-shift-related Migraine in Healthcare Professionals
Rimegepant 75 mg ODT, Standard Care - Migraine Disorders
Not applicableNot yet recruitingChinese PLA General Hospital2602026-12-012026-11-05
Long-term Safety of BR005-036C Tablets in the Acute Treatment of Migraine in Adults
BR005-036C - Migraine, With or Without Aura
Phase 3Not yet recruitingBrise Pharmaceuticals Co., Ltd.10002026-11-202026-11-12
Trigger Point Injection and Myofascial Release for Cervicogenic Headache
Trigger Point Injection + Home Exercise, Experimental: Myofascial Release + Home Exercise, Combined Trigger Point Injection and Myofascial Release - Cervicogenic Headache
Not applicableNot yet recruitingKonya Beyhekim Training and Research Hospital1202026-11-152026-11-02
Headache Education and Awareness vs. Daily Mindfulness Strategies - Understanding Pain
BREATHE with Headache (BREATHE-HA), Enhanced Standard-of-Care: Headache Education - Migraine, Migraine in Adolescence
Not applicableRecruitingUniversity of Colorado, Denver722026-11-102026-11-05
Biological Profiles of Neuropeptides, Neurotrophins and miRNA in Migraine
Rimegepant 75 MG - Migraine
Enrolling by invitationNordlandssykehuset HF602026-11-052026-11-10
Epidural Hydroxyethyl Starch for Post-Dural Puncture Headache in Parturients
Epidural hydroxyethyl starch, No epidural hydroxyethyl starch - Parturients, Accidental Puncture of Dura During Anaesthesia
RecruitingPeking University First Hospital4102026-11-042026-11-06

Showing 20 of 2137. Sign in to see all of them.

Narrower conditions

Migraine Disorders (1489)  ·  Headache (409)  ·  Post-Traumatic Headache (190)  ·  Tension-Type Headache (131)  ·  Cluster Headache (122)  ·  Post-Dural Puncture Headache (122)  ·  Migraine with Aura (114)  ·  Pain (113)  ·  Migraine without Aura (109)  ·  Headache Disorders, Secondary (52)  ·  Epilepsy (43)  ·  Headache Disorders, Primary (42)  ·  Neck Pain (40)  ·  Chronic Pain (31)

Broader conditions

Central Nervous System Diseases (2126)  ·  Nervous System Diseases (2124)  ·  Brain Diseases (2123)  ·  Headache Disorders, Primary (1705)  ·  Pathological Conditions, Signs and Symptoms (661)  ·  Signs and Symptoms (620)  ·  Neurologic Manifestations (600)  ·  Pain (434)  ·  Headache Disorders, Secondary (312)  ·  Trigeminal Autonomic Cephalalgias (111)  ·  Mental Disorders (87)  ·  Pathologic Processes (87)  ·  Behavior (85)  ·  Cardiovascular Diseases (66)

Interventions

Sumatriptan (74)  ·  Topiramate (59)  ·  erenumab (55)  ·  Sodium Chloride (54)  ·  rimegepant sulfate (43)  ·  Botulinum Toxins, Type A (38)  ·  Saline Solution (37)  ·  Naproxen (32)  ·  eptinezumab (29)  ·  Exercise (26)  ·  Lidocaine (26)  ·  Metoclopramide (26)  ·  fremanezumab (26)  ·  rizatriptan (25)  ·  Acetaminophen (23)

Sponsors

Danish Headache Center (102)  ·  Pfizer (43)  ·  Eli Lilly and Company (33)  ·  GlaxoSmithKline (31)  ·  Riphah International University (29)  ·  Allergan (25)  ·  Mayo Clinic (23)  ·  Amgen (22)  ·  Cairo University (21)  ·  IRCCS National Neurological Institute "C. Mondino" Foundation (21)  ·  AbbVie (20)  ·  Theranica (20)  ·  Montefiore Medical Center (19)  ·  Thomas Jefferson University (19)  ·  Merck Sharp & Dohme LLC (18)

Countries

United States (780)  ·  Denmark (159)  ·  Turkey (Türkiye) (151)  ·  Italy (122)  ·  Spain (109)  ·  Germany (96)  ·  Canada (95)  ·  France (94)  ·  China (81)  ·  United Kingdom (79)  ·  Egypt (73)  ·  Belgium (57)  ·  Norway (55)  ·  Pakistan (55)  ·  Israel (49)

Top investigators

Roger K Cady, MD (11)  ·  Alit Stark Inbar, PhD (7)  ·  Mia Minen, MD (6)

Results publications

PMID 11914403, PMID 12807523, PMID 8984084, PMID 39982105, PMID 31482569, PMID 32576229, PMID 33781209, PMID 17405970, PMID 31952501, PMID 34823467, PMID 35978286, PMID 37965170, PMID 11284464, PMID 25500317, PMID 29368949, PMID 30496104, PMID 31291516, PMID 33142014, PMID 34264500, PMID 34874514, PMID 34928306, PMID 35076090, PMID 36125279, PMID 36739511, PMID 37303034, PMID 38462625, PMID 39648629, PMID 41235617, PMID 41652666, PMID 42839212, PMID 11112243, PMID 16135345, PMID 17175134, PMID 17955107, PMID 18662331, PMID 19453963, PMID 19486178, PMID 19546766, PMID 20353434, PMID 20487038, PMID 20548058, PMID 20647241, PMID 20855373, PMID 21521204, PMID 21711255, PMID 21883197, PMID 22520687, PMID 22590713, PMID 23567060, PMID 23731663

NIH funding

2019 (16), 2015 (10), 2018 (10), 2023 (9), 2016 (8), 2008 (4), 2014 (4), 2017 (3), 2025 (3), 2004 (2), K01NS124911 (2), R01AT011005 (2), UL1TR001082 (2), 1IK2RX001136-01A2 (1), 1UG3AT013498-01 (1)